Candel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CADL and other ETFs, options, and stocks.

About CADL

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. 

CEO
Paul-Peter Tak
CEOPaul-Peter Tak
Employees
55
Employees55
Headquarters
Needham, Massachusetts
HeadquartersNeedham, Massachusetts
Founded
2002
Founded2002
Employees
55
Employees55

CADL Key Statistics

Market cap
719.51M
Market cap719.51M
Price-Earnings ratio
-10.05
Price-Earnings ratio-10.05
Dividend yield
Dividend yield
Average volume
2.73M
Average volume2.73M
High today
$10.50
High today$10.50
Low today
$9.58
Low today$9.58
Open price
$9.97
Open price$9.97
Volume
1.55M
Volume1.55M
52 Week high
$11.36
52 Week high$11.36
52 Week low
$4.35
52 Week low$4.35

Stock Snapshot

As of today, Candel Therapeutics(CADL) shares are valued at $9.80. The company's market cap stands at 719.51M, with a P/E ratio of -10.05.

On 2026-07-05, Candel Therapeutics(CADL) stock traded between a low of $9.58 and a high of $10.50. Shares are currently priced at $9.80, which is +2.3% above the low and -6.7% below the high.

Candel Therapeutics(CADL) shares are trading with a volume of 1.55M, against a daily average of 2.73M.

During the past year, Candel Therapeutics(CADL) stock moved between $4.35 at its lowest and $11.36 at its peak.

During the past year, Candel Therapeutics(CADL) stock moved between $4.35 at its lowest and $11.36 at its peak.

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own CADL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.